CytoDyn Inc.
- Close
- Oct 29, 2026 · +9.52%
- Market cap
- $337.99M
- 1.47B shares
- Filings
- 1,033
FY 2023−100.0% FY23 yoy
Q1 2027N/M FY26 yoy
Q1 2027N/M FY26 yoy
Q3 2022derivedN/M FY21 yoy
Q1 2027
Q1 2027−0.4% FY26 yoy
- $337.99M
- —
- —
- —
- —
- —
FY2026 figures · derived
Price
Oct 29, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-05-31 | $0 | reported | |
| FY 2022 | 2022-05-31 | $266,000 | reported | |
| FY 2021 | 2021-05-31 | $0 | reported |
Segments
Segments
LineFY2026ShareChange
Single reporting segment-$38.58M—N/M
Single reporting segment———
Total-$38.58M
Pharmaceutical preparations
CytoDyn Inc. is the 220th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
EBSEmergent BioSolutions Inc.$742.9M28.8%7.1%$302.3MARCTArcturus Therapeutics Holdings Inc.$82.0M46.1%80.2%$298.7M
CYDYCytoDyn Inc. (this company)———$293.9M
NIKANika Pharmaceuticals, Inc———$291.2MVOGXVogenx, Inc.———$283.9MFULCFulcrum Therapeutics, Inc.$0.0100.0%—$283.0MPREPrenetics Global LtdFiscal 2024 figures———$282.0MPRLDPrelude Therapeutics Inc$12.1M73.4%819.6%$280.9MLRMRLarimar Therapeutics, Inc.———$280.0MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
CytoDyn Inc. · CIK 1175680 · Engraved from SEC EDGAR